Revolve Wealth Partners LLC Takes $784,000 Position in Cardinal Health, Inc. $CAH

Revolve Wealth Partners LLC bought a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 3,300 shares of the company’s stock, valued at approximately $784,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of CAH. LWM Advisors Inc. lifted its position in shares of Cardinal Health by 4.4% in the second quarter. LWM Advisors Inc. now owns 1,028 shares of the company’s stock valued at $244,000 after buying an additional 43 shares during the last quarter. Kathmere Capital Management LLC increased its holdings in shares of Cardinal Health by 1.2% during the 1st quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock worth $896,000 after acquiring an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. raised its stake in Cardinal Health by 0.9% in the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after acquiring an additional 50 shares during the period. V Square Quantitative Management LLC raised its stake in Cardinal Health by 2.6% in the 1st quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock valued at $423,000 after acquiring an additional 50 shares during the period. Finally, Generali Asset Management SPA SGR lifted its holdings in Cardinal Health by 11.0% during the 4th quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after purchasing an additional 51 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.2%

CAH opened at $236.77 on Tuesday. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $244.87. The company has a 50-day simple moving average of $227.47 and a 200 day simple moving average of $216.44. The stock has a market capitalization of $55.45 billion, a price-to-earnings ratio of 36.20, a P/E/G ratio of 1.16 and a beta of 0.49.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Wells Fargo & Company decreased their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Citigroup raised their target price on shares of Cardinal Health from $245.00 to $265.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. Zacks Research lowered shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Finally, Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a research report on Friday, May 1st. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $251.73.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.